Clinical Outcomes After Implantation of a Monofocal Hydrophobic IOL, Bi-Flex 877PAY With POB-MA Preloaded Injector
1 other identifier
observational
100
1 country
1
Brief Summary
The purpose of our investigation is to retrospectively assess visual outcomes, refractive stability, safety features of the lens and the incidence of developing PCO (posterior capsular opacification) in a 12-month period following mono- or bilateral implantation of the hydrophobic acrylic monofocal IOL, Bi-Flex 877PAY (Medicontur).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 11, 2023
CompletedFirst Submitted
Initial submission to the registry
May 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedFirst Posted
Study publicly available on registry
June 21, 2024
CompletedJune 21, 2024
April 1, 2023
4 months
May 31, 2023
June 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Primary objective
To evaluate the monocular Uncorrected Distance Visual Acuity (UCDVA) 1 year after IOL implantation
12 months after IOL implantation
Secondary Outcomes (1)
Secondary onjective
12 months after IOL implantation
Eligibility Criteria
The enrolled subjects will be the patients who underwent cataract surgery in one or both eyes and who were implanted with Bi-Flex 877PAY IOL mono- or bilaterally. For evaluation of records consecutive implanted patients with regular post-operative visits over a 12 months period will be included.
You may qualify if:
- Male or female patients who underwent cataract surgery in one or both eyes and who were implanted with Bi-Flex 877PAY IOL mono- or bilaterally.
- Patients with regular post-operative visits over 12 months period after surgery.
- Patients of any age above 18 years and any medical history who are eligible according the investigator's decision.
You may not qualify if:
- preoperative corneal astigmatism \> 1.5 D
- uncontrolled diabetic retinopathy
- iris neovascularisation
- serious intraoperative complications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NHS Ayrshire and Arran
Ayr, Scotland, KA7 2SP, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sathish Srinivasan, Prof.
NHS Ayrshire and Arran
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2023
First Posted
June 21, 2024
Study Start
April 11, 2023
Primary Completion
July 31, 2023
Study Completion
December 1, 2023
Last Updated
June 21, 2024
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share